Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.
2.

The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex.

Kamińska K, Gołembiowska K, Rogóż Z.

Pharmacol Rep. 2014 Dec;66(6):984-90. doi: 10.1016/j.pharep.2014.06.009. Epub 2014 Jun 21.

PMID:
25443725
4.

Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.

Zhang W, Perry KW, Wong DT, Potts BD, Bao J, Tollefson GD, Bymaster FP.

Neuropsychopharmacology. 2000 Sep;23(3):250-62.

5.

Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex.

Huang M, Ichiwaka J, Li Z, Dai J, Meltzer HY.

Psychopharmacology (Berl). 2006 Apr;185(3):274-81. Epub 2006 Mar 7.

PMID:
16521036
6.

Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex.

Amargós-Bosch M, Artigas F, Adell A.

Eur J Pharmacol. 2005 Jun 15;516(3):235-8.

PMID:
15967429
7.
9.
10.

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

Hertel P, Nomikos GG, Iurlo M, Svensson TH.

Psychopharmacology (Berl). 1996 Mar;124(1-2):74-86.

PMID:
8935802
11.
12.

Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.

Johansson D, Falk A, Marcus MM, Svensson TH.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):143-8. doi: 10.1016/j.pnpbp.2012.06.003. Epub 2012 Jun 9.

PMID:
22691715
13.
15.
18.

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.

Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Wong DT, Perry KW.

Psychopharmacology (Berl). 2002 Apr;160(4):353-61. Epub 2002 Jan 29.

PMID:
11919662
Items per page

Supplemental Content

Write to the Help Desk